Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards

Teva’s Generic Version of EpiPen Now Available in the United States

By Teva Pharmaceutical Industries | November 29, 2018

Teva Pharmaceutical Industries announced the release of limited doses of the FDA-approved generic version of EpiPen1 (epinephrine injection, USP) Auto-Injector, 0.3 mg, in the U.S.

Teva’s generic version of the EpiPen Jr (epinephrine injection, USP) Auto-Injector, 0.15 mg, and an additional supply of Teva’s generic version of the EpiPen (epinephrine injection, USP) Auto-Injector, 0.3 mg is expected in 2019. The publically available Wholesale Acquisition Cost (WAC)2 for the product is $300.

Brendan O’Grady, EVP and head of North America Commercial at Teva said, “We’re pleased to provide access to Epinephrine Injection (Auto-Injector) for patients who may experience life-threatening allergic emergencies and we’re fully dedicated toward ensuring additional supply in 2019.”

With over 550 generic medicines available, Teva has the largest portfolio of FDA-approved generic products on the market. Currently, one in seven generic prescriptions dispensed in the U.S. is filled with a Teva generic product.
____________________________________________________________

References:

1 EpiPen and EpiPen Jr are registered trademarks of Mylan.

2 Teva does not set the price that a pharmacy charges for a particular drug and does not has visibility or control into the price of the drug in the marketplace.

(Source: Teva Pharmaceutical Industries)

Related Articles Read More >

President Joe Biden
Biden to order analysis of pharma supply chain
5 takeaways from the latest White House COVID-19 response team briefing
Pfizer-BioNTech vaccine
Pfizer vaccine stable at standard freezer temps, effective with single dose
Biden
Why Big Tech is offering Biden help with COVID-19 vaccination

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Pharmaceutical Processing World
  • Enews Signup
  • Contact Us
  • About Us
  • R&D World
  • DeviceTalks
  • Drug Discovery & Development
  • Drug Delivery Business News
  • MassDevice
  • Medical Design Sourcing

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards